fda compounding restrictions bpc-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank 🚨 BREAKING: U.S. Regulators to

BREAKING: U.S. Regulators to Review Controversial Peptides Backed by RFK Jr. U.S. health regulators are preparing to review whether several controversial peptide compounds should be allowed to be made by compounding A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! FDA advisory committee votes to add popular peptide BPC 157 to drug compounding list ABC News 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval The FDA cracked down on BPC 157 and now the biohackers are losing their minds

SKU: 51266057443 · From hgidocs.co